Acoustic Emission Biomarkers for the Detection and Monitoring of Early Knee Osteoarthritis
1 other identifier
observational
120
1 country
1
Brief Summary
The aim of this exploratory study is to further investigate the potential of acoustic emission biomarkers, assessed by the inmodi knee brace, to diagnose osteoarthritis (OA) at earlier stages. Therefore, 20 healthy participants and 100 patients with increased risk of knee OA will be recruited from the Schulthess Klinik in Zurich and examined twice with 9 ± 3 months' time interval. Anthropometric data, EOS radiographs and MR images of both knees, PROMs and acoustic emission data will be collected and evaluated. Artificial Intelligence algorithm will then be used to identify and validate the most promising acoustic emission biomarkers with a prognosis value in the prediction of knee osteoarthritis progress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
October 25, 2023
CompletedFirst Posted
Study publicly available on registry
April 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 19, 2024
April 1, 2024
1.6 years
October 25, 2023
April 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
acoustic emissions
Acoustic sensors are embedded in the hardware of the inmodi knee brace, allowing the non-invasively collection of acoustic data at frequencies between 100Hz and 20 kHz. During data analysis, signals will be segmented and frequency components of low interest will be removed. Specific sound features, such as spectral, fractality, peak amplitude or click patters will be extracted. Data of both knees will be assessed at the same time with the inmodi knee brace (v2) during four different tests, based on recommendations by the Osteoarthritis Research Society International (OARSI) for people with knee OA: - unloaded flexion-extension (F/E) of the knee in a seated position, - Sit-to-Stand test (STS), - One-step test (OST), - Walk test. Associations between the extracted sound parameters and kinematic data, MOAKS grading, KL grading, leg alignment angles and PROMS will be studied to identify biomarkers with a prognosis value in the prediction of OA progress.
1 year and 2 years
kinematic data
Inertial sensors, also embedded in the hardware, do collect movement trajectories at the same time during the four different tests. This kinematic data will be combined with the acoustic emissions to analyze which sound features appear at specific ranges of motion (knee flexion/extension).
1 year and 2 years
MRI / MOAKS
Patients will be scanned using a 3T MRI scanner (Magnetom Prisma, Siemens). MRI allow to visualize and assess structural changes in joint tissues, such as cartilage, meniscus and subchondral bone. Semi-quantitative scoring of these degenerative structures in OA will be done using the MRI Osteoarthritis Knee Score (MOAKS) system by a radiologist.
1 year and 2 years
EOS / leg alignment
Bilateral long-leg radiographic images will be acquired in a standing position as stereoradiography using the EOS Edge (EOS X-Ray Imaging Acquisition System, Paris, France). Images will be analyzed for OA grading (Kellgren-Lawrence grade 0 - 4) and leg alignment parameters (hip-knee-ankle angle, mechanical axis length and deviation, proximal tibia width and compartmental joint space width).
1 year and 2 years
PROMS
Five different patient reported outcome measures are used: * Oxford Knee Score: contains 12 questions about individual's activities of daily living and how they have been affected by pain over the last 4 weeks. * Core Outcome Measures Index Knee: assesses the main outcomes of importance to patients with knee problems (pain, function, symptom-specific well-being, quality of life, disability). * University of California at Los Angeles: an activity rating scale, which rates the activity level of joint replacement patients globally in one out of 10. * Knee injury and osteoarthritis outcome score: an instrument to assess the patient's opinion about their knee and associated problems. * Forgotten Joint Score 12 is a concise 12-item PROM that evaluates patients' ability to forget their joint in daily life.
1 year and 2 years
Study Arms (6)
A: healthy participants
20 healthy participants judging themselves to be of good subjective health without any knee problems
B1: 2 years normal
20 patients from the knee registry at 2 years post-op with normal outcomes
B2: 2 years poor
20 patients from the knee registry at 2 years post-op with poor outcomes
C1: 5 years normal
20 patients from the knee registry at 5 years post-op with normal outcomes
C2: 5 years poor
20 patients from the knee registry at 5 years post-op with poor outcomes
D: TKA patients
20 patients booked for unilateral TKA surgery for severe OA
Interventions
All diagnosis tests
Eligibility Criteria
This study targets a population at risk of OA. The risk of knee OA after knee joint injury is up to five-fold that of non-injured patients. As much as 50% of individuals with an anterior cruciate ligament (ACL) or meniscus tear develop knee OA. Therefore, to represent the whole distribution of OA stages in the study sample, participants will be recruited from the Meniscus/ACL-surgery (MAC) registry of the Schulthess Klinik at 2 years and 5 years post-operative times. Additionally, a healthy control group and a late-stage OA group will be included.
You may qualify if:
- Group A: persons judging themselves to be of good subjective health without any knee problems, aged 35-65 years
- Groups B\&C: participant in MAC registry, completed patient reported-outcome measurements (PROM) questionnaires at 2y or 5y within the last 6 months, aged 35-65 years, unilateral knee surgery (another side as internal control), B1/C1: the normal group is defined as patients closely around the median COMI scores of their respective group (determined medians are: 2yr females: 0.9 / 2yr males: 0.7 / 5yr females: 0.5 / 5yr males: 0.5), B2/C2: the poor outcomes group consists of patients with scores ≥ 2.
- Group D: patient booked for TKA due to severe OA, aged 35-75 years
You may not qualify if:
- inability to give consent or follow procedures
- no understanding of German language
- open wounds or tissue injuries
- irritated or infected sections on the limbs
- Class II obesity defined by Body Mass Index (BMI) ≥ 35 kg/m2 (comorbidities associated with obesity should be investigated in future studies)
- uncooperative patients who disregard or cannot follow instructions, including those who abuse drugs and/or alcohol
- Pregnant or with intention to get pregnant (x-rays)
- Current address outside of Switzerland
- Groups B\&C: revision surgeries at the operated knee, death, known pathologies or former injuries of the comparator knee
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Schulthess Kliniklead
- Ecole Polytechnique Fédérale de Lausannecollaborator
Study Sites (1)
Schulthess Klinik
Zurich, Canton of Zurich, 8008, Switzerland
Related Publications (8)
Leifer VP, Katz JN, Losina E. The burden of OA-health services and economics. Osteoarthritis Cartilage. 2022 Jan;30(1):10-16. doi: 10.1016/j.joca.2021.05.007. Epub 2021 May 20.
PMID: 34023527BACKGROUNDKELLGREN JH, LAWRENCE JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957 Dec;16(4):494-502. doi: 10.1136/ard.16.4.494. No abstract available.
PMID: 13498604BACKGROUNDEckstein F, Wirth W. Quantitative cartilage imaging in knee osteoarthritis. Arthritis. 2011;2011:475684. doi: 10.1155/2011/475684. Epub 2010 Dec 8.
PMID: 22046518BACKGROUNDvan Spil WE, Szilagyi IA. Osteoarthritis year in review 2019: biomarkers (biochemical markers). Osteoarthritis Cartilage. 2020 Mar;28(3):296-315. doi: 10.1016/j.joca.2019.11.007. Epub 2019 Dec 27.
PMID: 31887390BACKGROUNDKalo K, Niederer D, Stief F, Wurzberger L, van Drongelen S, Meurer A, Vogt L. Validity of and recommendations for knee joint acoustic assessments during different movement conditions. J Biomech. 2020 Aug 26;109:109939. doi: 10.1016/j.jbiomech.2020.109939. Epub 2020 Jul 8.
PMID: 32807320BACKGROUNDPrior J, Mascaro B, Shark LK, Stockdale J, Selfe J, Bury R, Cole P, Goodacre JA. Analysis of high frequency acoustic emission signals as a new approach for assessing knee osteoarthritis. Ann Rheum Dis. 2010 May;69(5):929-30. doi: 10.1136/ard.2009.112599. No abstract available.
PMID: 20413570BACKGROUNDShakya BR, Tiulpin A, Saarakkala S, Turunen S, Thevenot J. Detection of experimental cartilage damage with acoustic emissions technique: An in vitro equine study. Equine Vet J. 2020 Jan;52(1):152-157. doi: 10.1111/evj.13132. Epub 2019 Jun 6.
PMID: 31032989BACKGROUNDBahador N, Pfeifle J, Thevenot J, et al. Evaluating the Potential of Novel Biomarkers for Characterizing Deviation of Acoustic Dynamics from Self-similarity in Osteoarthritic Knees (Manuscript in preparation). Published online 2021.
BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vincent A Stadelmann, PhD
Schulthess Klinik
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 25, 2023
First Posted
April 8, 2024
Study Start
January 1, 2023
Primary Completion
July 31, 2024
Study Completion
December 31, 2024
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share